Medtronic (MDT) Net Cash Flow Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 42.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -87.88% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -48.90% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 129.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -65.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 33.47% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -51.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | 42.74% |
| Oct 24, 2025 | -74.18% |
| Jul 25, 2025 | 11.34% |
| Apr 25, 2025 | 22.40% |
| Jan 24, 2025 | -26.81% |
| Oct 25, 2024 | 41.47% |
| Jul 26, 2024 | 80.59% |
| Apr 26, 2024 | 42.54% |
| Jan 26, 2024 | 29.84% |
| Oct 27, 2023 | 46.71% |
| Jul 28, 2023 | -27.52% |
| Apr 28, 2023 | -97.92% |
| Jan 27, 2023 | -46.93% |
| Oct 28, 2022 | 65.82% |
| Jul 29, 2022 | -60.31% |
| Apr 29, 2022 | -18.42% |
| Jan 28, 2022 | 68.28% |
| Oct 29, 2021 | 40.28% |
| Jul 30, 2021 | -39.39% |
| Apr 30, 2021 | 18.22% |
| Jan 29, 2021 | -56.40% |
| Oct 30, 2020 | -29.19% |
| Jul 31, 2020 | 107.96% |
| Apr 24, 2020 | -38.66% |
| Jan 24, 2020 | -14.90% |
| Oct 25, 2019 | -127.97% |
| Jul 26, 2019 | 86.26% |
| Apr 26, 2019 | 176.55% |
| Jan 25, 2019 | -36.94% |
| Oct 26, 2018 | 8.91% |
| Jul 27, 2018 | 33.95% |
| Apr 27, 2018 | 39.59% |
| Jan 26, 2018 | -63.55% |
| Oct 27, 2017 | 416.14% |
| Jul 28, 2017 | -84.63% |